logo
Brisbane News Live: Tributes flow for Gold Coast developer after death at 39; Giant Qld stick insect ‘Australia's heaviest'

Brisbane News Live: Tributes flow for Gold Coast developer after death at 39; Giant Qld stick insect ‘Australia's heaviest'

Latest posts
Latest posts
7.03am
Tributes for 'pioneer' Gold Coast property developer after sudden death at 39
Gold Coast property developer Tye Alroe has died suddenly at the age of 39.
The founder and chief executive of Alroe Constructions suffered a heart attack while exercising at a Burleigh Heads gym on Tuesday afternoon.
He collapsed after feeling unwell, and emergency service workers were unable to revive him.
Alroe initially embarked on a career in rugby league, being contracted by NRL side Melbourne Storm, but he left before making his debut and entered the construction industry instead.
In 2012, he founded Alroe, which currently has $250 million worth of projects under way or in planning, according to its website.
Several figures within the Gold Coast construction industry paid tribute to him after his sudden death.
'The loss of a pioneer, someone that never quits, never takes no as an answer! You will never be forgotten,' says an Instagram post from Capra Build Co.
'Unfortunately, we have lost one of the better people in this world,' begins an Instagram post by Callum Smith of Bluewater Interiors. 'I'm sure you will be missed by many. You have made a positive impact on so many people and will no doubt be remembered.'
Alroe is survived by his partner, Nikki, daughter Poppy, his mum and dad, Vicki and John, and his sister, Courtney.
7.02am
While you were sleeping
Here's what's making news further afield this morning:
The nation's top spy boss has revealed espionage is costing Australia an estimated $12.5 billion a year as foreign operatives mount increasingly audacious attempts to pilfer highly sensitive defence and business secrets.
Median house values across the country are gaining pace, with Brisbane now at $1.019 million.
A monster lightning strike that spanned the equivalent distance of Sydney to Melbourne has been confirmed as the largest flash on record.
Company tax could be slashed to 20 per cent for firms with revenue below $1 billion, but businesses would be hit with a world-first 'cashflow tax' to encourage them to invest in Australia.
Prime Minister Anthony Albanese's allies are scrambling to put a lid on an anti-AUKUS grassroots Labor move that threatens to complicate a US probe into the submarine pact.
If you have brittle nails, swollen hands or unusually pale fingertips, it could be a telltale sign of a more serious problem. This is what your hands can tell you about your health.
And in sport, Mollie O'Callaghan has equalled Ian Thorpe for the most world championship gold medals by an Australian swimmer after anchoring the Dolphins to a stirring relay victory over the US in the 4x200m freestyle final overnight.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines
‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

Sydney Morning Herald

time28 minutes ago

  • Sydney Morning Herald

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

Health Minister Mark Butler is planning to speed up medicines approvals as United States President Donald Trump threatens to put tariffs of up to 250 per cent on pharmaceutical products, which could affect $2 billion worth of Australian exports. Butler said Trump's latest threat would not change the discount Australians received on medicines through the Pharmaceutical Benefits Scheme, but revealed he would get advice within days about accelerating the approvals process for new drugs in Australia – a key issue that US pharmaceutical giants have raised with Trump. Speeding up the timeframe for US medicines to land on pharmacy shelves could improve the Australian government's standing with the Trump administration, although it does not deal with the White House's bigger concern that Americans pay more for medicines than citizens of other countries. Trump's anger with what he called 'foreign freeloading nations' prompted him to threaten tariffs of up to 250 per cent on drug imports this week. Butler said it was a 'a very big threat'. 'It's one we're working very hard to engage with the Americans on,' Butler said on Thursday. Loading 'The numbers are jumping around … They were 200 per cent a couple of weeks ago, and now they're 250 per cent potentially. They are very, very big tariffs. 'We are making the case very strongly, but I'm not going to pretend that the US Administration doesn't appear to be pretty serious about this.' Australia's PBS – under which the government subsidises drugs and Australians can buy expensive medicines for a maximum price of $31.60, soon to become $25 – has been brought up repeatedly during Trump's trade wars as US pharmaceutical companies push the president to punish countries that limit their market access.

‘Bad timing': US-India tensions throw Albanese-Trump meeting into doubt
‘Bad timing': US-India tensions throw Albanese-Trump meeting into doubt

Sydney Morning Herald

time28 minutes ago

  • Sydney Morning Herald

‘Bad timing': US-India tensions throw Albanese-Trump meeting into doubt

Prime Minister Anthony Albanese's plans to meet US President Donald Trump in India next month have been thrown into turmoil by the intensifying trade battle between Washington and New Delhi, raising doubts about the future of a four nation grouping's ability to counter China. Trump announced on Thursday that he would double tariffs on Indian exports to the United States to 50 per cent, among the highest in the world, to punish the nation for buying oil from Russia, sparking an angry reaction from New Delhi. Indian Prime Minister Narendra Modi has been preparing to host the leaders of Australia, the US and Japan for a summit of the Quad grouping in early September, providing a platform for Albanese's first in-person meeting with Trump. The Quad leaders have met every year since 2021 as part of the high-profile partnership designed to showcase the ability of the nations to work together as a democratic counterweight to authoritarian China's growing influence in the Indo-Pacific. Beijing has loathed the Quad since its inception, blasting it as an 'exclusive clique' and falsely characterising it as an 'Asian NATO', although the group is not underpinned by a treaty. Ian Hall, an expert on Indian politics at Griffith University, said it was 'a toss up' whether the September summit, which has not been formally confirmed, would go ahead given the rising hostility between Trump and Modi, who until recently revelled in a seemingly friendly relationship. 'The Quad is going to have to come up with a whole new agenda and to find a way to hold a summit in India. It's very unclear if that will happen,' he said. 'For 25 years, the US has seen India's rising prosperity and influence as being in its interests. That has just disappeared under 'America first' and that's a big problem.' Albanese tried to meet Trump to discuss issues including tariffs and AUKUS at a meeting of the G7 group of countries in June, but the president left early as conflict escalated in the Middle East.

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines
‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

The Age

time28 minutes ago

  • The Age

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

Health Minister Mark Butler is planning to speed up medicines approvals as United States President Donald Trump threatens to put tariffs of up to 250 per cent on pharmaceutical products, which could affect $2 billion worth of Australian exports. Butler said Trump's latest threat would not change the discount Australians received on medicines through the Pharmaceutical Benefits Scheme, but revealed he would get advice within days about accelerating the approvals process for new drugs in Australia – a key issue that US pharmaceutical giants have raised with Trump. Speeding up the timeframe for US medicines to land on pharmacy shelves could improve the Australian government's standing with the Trump administration, although it does not deal with the White House's bigger concern that Americans pay more for medicines than citizens of other countries. Trump's anger with what he called 'foreign freeloading nations' prompted him to threaten tariffs of up to 250 per cent on drug imports this week. Butler said it was a 'a very big threat'. 'It's one we're working very hard to engage with the Americans on,' Butler said on Thursday. Loading 'The numbers are jumping around … They were 200 per cent a couple of weeks ago, and now they're 250 per cent potentially. They are very, very big tariffs. 'We are making the case very strongly, but I'm not going to pretend that the US Administration doesn't appear to be pretty serious about this.' Australia's PBS – under which the government subsidises drugs and Australians can buy expensive medicines for a maximum price of $31.60, soon to become $25 – has been brought up repeatedly during Trump's trade wars as US pharmaceutical companies push the president to punish countries that limit their market access.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store